Sunflower Pharmaceutical Group Co.,Ltd (SHE:002737)
China flag China · Delayed Price · Currency is CNY
15.69
+0.06 (0.38%)
Apr 30, 2025, 3:04 PM CST

SHE:002737 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 2015 - 2019
Operating Revenue
2,5073,3625,6865,0834,4543,457
Upgrade
Other Revenue
14.9414.9414.6211.036.554.83
Upgrade
Revenue
2,5223,3775,7005,0954,4613,462
Upgrade
Revenue Growth (YoY)
-53.74%-40.76%11.89%14.20%28.86%-20.81%
Upgrade
Cost of Revenue
1,6561,8962,4932,1571,8221,450
Upgrade
Gross Profit
866.491,4813,2082,9382,6392,012
Upgrade
Selling, General & Admin
506.8854.081,8391,7511,6431,192
Upgrade
Research & Development
121.33124.13128.6594.61132.07113.56
Upgrade
Other Operating Expenses
36.7442.2560.8269.465.5651.03
Upgrade
Operating Expenses
672.591,0282,0241,9161,8671,350
Upgrade
Operating Income
193.9452.831,1841,022771.33661.92
Upgrade
Interest Expense
-3.47-3.56-5.97-9.73-10.19-7.39
Upgrade
Interest & Investment Income
40.6252.2185.3530.5644.0929.02
Upgrade
Currency Exchange Gain (Loss)
0.050.05-0.090.11--
Upgrade
Other Non Operating Income (Expenses)
0.881.08-2.42-4.56-0.24-0.8
Upgrade
EBT Excluding Unusual Items
231.97502.611,2601,039805682.74
Upgrade
Impairment of Goodwill
-4.8-4.8--15.83-27.22-36.73
Upgrade
Gain (Loss) on Sale of Investments
-7.98-12.99-16.39-19.312.67-
Upgrade
Gain (Loss) on Sale of Assets
-0.24-0.243.237.4347.77-5.41
Upgrade
Asset Writedown
-20.27-20.99-0.48-10.6-2.46-1.97
Upgrade
Other Unusual Items
168.37170.89108.0280.6368.76128.2
Upgrade
Pretax Income
367.05634.491,3551,081894.51766.83
Upgrade
Income Tax Expense
75.78131.76189.83171.37132.16146.89
Upgrade
Earnings From Continuing Operations
291.27502.731,165909.73762.35619.94
Upgrade
Minority Interest in Earnings
2.7-10.69-45.8-42.51-57.61-35.48
Upgrade
Net Income
293.97492.051,119867.22704.74584.45
Upgrade
Net Income to Common
293.97492.051,119867.22704.74584.45
Upgrade
Net Income Growth
-69.64%-56.03%29.05%23.06%20.58%3.37%
Upgrade
Shares Outstanding (Basic)
584586583586582584
Upgrade
Shares Outstanding (Diluted)
584586583586582584
Upgrade
Shares Change (YoY)
0.13%0.49%-0.53%0.61%-0.35%0.27%
Upgrade
EPS (Basic)
0.500.841.921.481.211.00
Upgrade
EPS (Diluted)
0.500.841.921.481.211.00
Upgrade
EPS Growth
-69.67%-56.25%29.73%22.31%21.00%3.09%
Upgrade
Free Cash Flow
-495.96-400.27740.521,822746.92957.14
Upgrade
Free Cash Flow Per Share
-0.85-0.681.273.111.281.64
Upgrade
Dividend Per Share
0.5000.5001.5001.0000.7000.350
Upgrade
Dividend Growth
-66.67%-66.67%50.00%42.86%100.00%-65.00%
Upgrade
Gross Margin
34.35%43.85%56.27%57.67%59.15%58.12%
Upgrade
Operating Margin
7.69%13.41%20.76%20.07%17.29%19.12%
Upgrade
Profit Margin
11.65%14.57%19.63%17.02%15.80%16.88%
Upgrade
Free Cash Flow Margin
-19.66%-11.85%12.99%35.77%16.74%27.65%
Upgrade
EBITDA
366.23625.661,3581,285935.8811.07
Upgrade
EBITDA Margin
14.52%18.53%23.83%25.22%20.98%23.43%
Upgrade
D&A For EBITDA
172.33172.83174.82262.65164.47149.15
Upgrade
EBIT
193.9452.831,1841,022771.33661.92
Upgrade
EBIT Margin
7.69%13.41%20.76%20.07%17.29%19.12%
Upgrade
Effective Tax Rate
20.65%20.77%14.01%15.85%14.77%19.16%
Upgrade
Revenue as Reported
2,5223,3775,7005,0954,4613,462
Upgrade
Advertising Expenses
-217.861,0781,068115.37127.86
Upgrade
Updated Oct 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.